1,897 results on '"Crowe, James E."'
Search Results
2. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
3. Ebola vaccine–induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects
4. A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection
5. Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination
6. Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin
7. Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode
8. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
9. Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies
10. Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody.
11. Broad dengue neutralization in mosquitoes expressing an engineered antibody.
12. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
13. Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies
14. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
15. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
16. Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines
17. Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial
18. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition
19. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors
20. A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
21. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions
22. A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
23. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
24. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
25. Pneumoviruses: Respiratory Syncytial Virus and Human Metapneumovirus
26. Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity
27. Transient Generalized Osteosclerosis in a Newborn Mimicking Congenital Osteopetrosis with Negative Comprehensive Genetic Workup: A Case Report
28. Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody
29. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
30. Immune correlates of protection for dengue: State of the art and research agenda
31. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody
32. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations
33. SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
34. Developing a Prototype Pathogen Plan and Research Priorities for the Alphaviruses
35. Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
36. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
37. Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses
38. Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies
39. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates
40. Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
41. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
42. Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface
43. Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance
44. Correlation of clinical and chest radiograph findings in pediatric submersion cases
45. Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein
46. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications
47. Computationally restoring the potency of a clinical antibody against Omicron
48. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
49. Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses
50. Host range, transmissibility and antigenicity of a pangolin coronavirus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.